Seven Fleet Capital Management »

Verastem shares owned by Seven Fleet Capital Management

Quarter-by-quarter ownership of Verastem (VSTM) shares owned by Seven Fleet Capital Management from 13F filings

Historical chart of Seven Fleet Capital Management investment in Verastem

Tip: Access up to 7 years of quarterly data

All positions including Verastem held by Seven Fleet Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verastem by Seven Fleet Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $117k 15k 7.72

More positions owned by Seven Fleet Capital Management

Cg Oncology (CGON)
Soleno Therapeutics (SLNO)
Revolution Medicines (RVMD)
Liquidia Corporation Com New (LQDA)
Compass Therapeutics (CMPX)
Exelixis (EXEL)
Axsome Therapeutics (AXSM)
Tyra Biosciences (TYRA)
Cogent Biosciences (COGT)
Tango Therapeutics (TNGX)
Xencor (XNCR)
Pharvaris N V (PHVS)
Terns Pharmaceuticals (TERN)
Belite Bio Sponsored Ads (BLTE)
Dyne Therapeutics (DYN)

View all positions for Seven Fleet Capital Management

Top funds holding Verastem

Rtw Investments
Deep Track Capital
BlackRock
Vanguard Group
Balyasny Asset Management
Polar Capital Holdings
State Street Corporation
Stonepine Capital Management
Foresite Capital Management VI
Armistice Capital
Farallon Capital Management
Rosalind Advisors
Logos Global Management
Goldman Sachs Group
Geode Capital Management

View all funds holding Verastem